There are some solid biotech stocks on the market. But there are many more that deserve an âFâ rating from the Portfolio Grader. More
Articles
This B-Rated Fintech Stock Should Be on Your Watchlist Right Now
In the event Yiren's diversification efforts lead to continued strong results, and issues like the post-Covid slump subside, this could lead to a resurgence in investor confidence. In turn, this may result in a massive re-rating for YRD stock. More
Don’t Expect Super Returns From American Superconductor Stock
American Superconductor was thrust into the spotlight for a hot minute, but AMSC stock's moonshot moment wasn't destined to last long. More
Block Buy Alert: Expect a Triumphant Return to $80 for SQ Stock
Not all tech stocks have been high flyers in 2023, as SQ stock is down despite the continued success of Block's Cash App. More